We haven't heard anything about the MoU signed with Celularity in 2018. Its seems the company, that's science includes pluripotent stem cells, rallied some 113% in one day (yes I do own) on raising its full-year 2024 net sales guidance to $54-60 million, up from the previously announced $50-56 million and expected net sales of $44.4 million through October 2024....
I can't help wonder if some of the rally on RFK's positive comments on stem cells as I posted in other threads.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.15M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.5¢ | 16.0¢ | $62.06K | 386.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 70000 | 2 |
View Market Depth
| Last trade - 14.47pm 25/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |